Interestingly, we did not find that PB could inhibit the activation of the PI3K/Akt signaling pathway; instead, blocking the TRIB3-AKT1 interaction led to an upregulation of AKT phosphorylation levels, which did not contribute to tumor progression. The gene discussed is TRIB3; the disease is neoplasm.